Image

Global Octreotide Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Octreotide Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Octreotide Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 3.00 USD Billion
Diagram Market Size (Forecast Year) USD 3.80 USD Billion
Diagram CAGR %

Major Markets Players

  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • China National Pharmaceutical Group Corporation
  • Sihuan Pharmaceutical Holdings Group Ltd
  • Shanghai Soho

Global Octreotide Market, By Type (octreotide acetate, octreotide, octreotide chloride, octreotide hydrochloride, indium In-111; octreotide), Form (Injection, Powder, Microspheres), Indications (Diarrhoea, Acromegaly, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Octreotide Market

Octreotide Market Analysis and Size

Growing incidence of disease such as acromegaly and cancer, is anticipated to surge the demand for octreotide drugs, which in turn is expected to drive the market growth. The demand is greatly increased by increasing number of people under the diagnosis of cancer. In 2021, 1,898,160 new cancer cases and 608,570 cancer deaths are projected to occur in the U.S. The growing popularity of generic drugs might affect the consumption of branded drugs.

Data Bridge Market Research analyses a growth rate in the octreotide market in the forecast period 2023-2030. The expected CAGR of octreotide market is tend to be around 3% in the mentioned forecast period. The market was valued at USD 3 billion in 2022, and it would grow upto USD 3.80 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Octreotide Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (octreotide acetate, octreotide, octreotide chloride, octreotide hydrochloride, indium In-111; octreotide), Form (Injection, Powder, Microspheres), Indications (Diarrhoea, Acromegaly, Others), End-Users (Veterinary Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), China National Pharmaceutical Group Corporation (China), Sihuan Pharmaceutical Holdings Group Ltd (China), Shanghai Soho-Yiming Pharmaceuticals Co.,Ltd. (China)

Market Opportunities

  • Growing Drug Launches
  • Increasing Rates of Cancer

Market Definition

Octreotide is a type of hormone drug which is used to treat some types of cancer. It is sold under the brand name Sandostatin among others and is a long-acting injection used to control acromegaly and carcinoid tumours in people. This class of medications is also known as octapeptides. This medication is also used to treat extreme watery diarrhoea and sudden reddening of the face. This medication works by hindering the production of natural substances hormones.  

Octreotide Market Dynamics

Drivers

  • Increasing Pipeline of Drugs

The robust pipeline of drugs in clinical trials is expected to boost the market growth. For instance, in 2016, Mario Negri Institute for pharmacological research completed phase 2 clinical trials of its Octreotide LAR along with tolvaptan drug used for the treatment of autosomal dominant polycystic kidney disease. Octreotide sponsored by Radbound University is in phase 3 clinical trials from 2016. This drug is under clinical trial for the treatment of vascular malformations, angiodysplasia, gastrointestinal hemorrhage, and anemia with octreotide. Injection Octreotide, which is sponsored by PVS memorial hospital is in phase 4 clinical trials since 2016. This injection is precisely used for treatment of pancreatic fistula and complications of pancreatoduodenectomy among patients with soft pancreas. Moreover, CAM2029 is being tested, that is currently in phase 2, for acromegaly and neuroendocrine tumors by Camurus AB in collaboration with Novartis AG. Octreotide chloride is the active ingredient for this product.

Opportunities

  • Growing Drug Launches

A growing number of launches relating to novel Octreotide acetate products by major market players is anticipated to drive market growth. For instance, in 2013, Sagent Pharmaceuticals, which is a U.S.-based biopharmaceutical company, launched its new drug Octreotide acetate, a samatostatin analog. This drug is used to decrease blood levels of IGF-I and growth hormone in acromegaly patients who do not sufficiently respond to or who cannot be treated by surgery, irradiation and bromocriptine mesylate.

  • Increasing Rates of Cancer

The global demand for octreotide is boosted by increasing number of people under the diagnosis of cancer. In 2012, there were projected 14.1 million cases of cancer .It is expected that by 2035, the number of people surviving from cancer will be about 24 million. These estimate shows that the demand for treatment drugs such as octreotide will grow. It is estimated that about 2200 children die every day because of severe diarrhea, more than Aids, malaria and measles combined.

 Restraints/Challenges

  • High Cost of Treatment

The enormous expenditure associated with the treatment of octreotide impede the market growth. The treatment becomes quite unaffordable in middle-income countries, thus, in a way limiting the market growth.

This octreotide market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the octreotide market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth

Global Octreotide Market Scope

The octreotide market is segmented on the basis of type, form, indications, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • octreotide acetate
  • octreotide
  • octreotide chloride
  • octreotide hydrochloride
  • indium In-111; octreotide

Form

  • Injection
  • Powder
  • Microspheres

Indications

  • Diarrhoea
  • Acromegaly
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Octreotide Market Regional Analysis/Insights

The octreotide market is analyzed and market size insights and trends are provided by type, form, indications, distribution channel and end-user as referenced above.

The major countries covered in the octreotide market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for octreotide market throughout the forecasted period due to increased new research and developments on octreotide market.  

North America dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Octreotide Market Share Analysis

The octreotide market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to octreotide market.

Key players operating in the octreotide market include:

  • Novartis AG (Switzerland)
  • Sun Pharmaceutical Industries Ltd. (India)
  • China National Pharmaceutical Group Corporation (China)
  • Sihuan Pharmaceutical Holdings Group Ltd (China)
  • Shanghai Soho-Yiming Pharmaceuticals Co.,Ltd. (China)
  • JB Pharma (India)
  • Samarth Life Sciences Pvt. Ltd. (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The octreotide market size will be worth USD 3.80 billion by 2030.
The growth rate of the octreotide market is 3% during the forecast period by 2030.
The robust pipeline of drugs in clinical trials is the growth driver of the octreotide market.
Type, form, indications, distribution channel, and end-user are the factors on which the octreotide market research is based.
Major companies in the octreotide market are Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), China National Pharmaceutical Group Corporation (China), Sihuan Pharmaceutical Holdings Group Ltd (China), Shanghai Soho-Yiming Pharmaceuticals Co.,Ltd. (China).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials